The HRA is currently reviewing all its website material to ensure greater consistency in the use of language in conveying standards that should be followed (ethical obligations or best practice) or must be followed (legal requirements). Readers should be aware that the HRA holds both in high regard. For further information please see the HRA website conditions which can be found here.
We have developed six new eLearning modules as an aid for researchers, R&D staff, study sponsors, research ethics committee members and the wider research community.
The modules are relevant to all four nations of the UK and cover key areas …
A combined IRAS form that merges the Research Ethics Committee (REC) and R&D forms is now being used across the UK.
Following its successful use for projects where the lead NHS R&D office is based in England, the single IRAS …
‘Significant progress’ has been made in medical research regulation and governance over the past five years, according to a report of an Academy of Medical Sciences workshop published this week.
Leading figures from the world of UK medical research attending …
Twitter users searching for #HRAtips can get advice on submitting studies for HRA Approval as part of a new campaign to help applicants avoid common mistakes in their research proposals.
We already offer a wealth of guidance and advice to …
We’ve worked with the NHS R&D Forum to create a short animation to explain HRA Approval and to illustrate the experience of researchers applying for approvals before and after its development.
The animation is designed for anyone with an interest …
Researchers working across the four United Kingdom countries should find it easier to set up and carry out health research across the NHS and Health and Social Care in Northern Ireland (HSC). This is thanks to the UK research approval …
Health and social care researchers used to be faced with a very complex regulatory system – everyone agreed we needed a new approach. So we consulted with a wide range of stakeholders to develop HRA Approval, which brings together the …
The first study to ever go through HRA Approval has now been completed.
The study, led by NHS South Norfolk Clinical Commissioning Group (CCG), looked into interagency working across local health agencies, local authorities and the police in safeguarding …
Biotechnology company Amgen was keen to get HRA Approval for an international research study into the effectiveness of a new treatment for patients with aggressive B-cell Non-Hodgkin’s lymphoma.
Amgen wanted to examine the use of a drug delivered intravenously to …
Joint Head of Policy at the HRA, Amanda Hunn, speaking at the 2015 R&D Forum.
The Annual NHS R&D Forum is taking place in Manchester on May 15 and 16 – the must-attend meeting of the year for those working …